The Medicines Discovery Catapult

The Medicines Discovery Catapult is the centre of national expertise for the discovery of medicines.

The Medicines Discovery Catapult (“the Catapult” or “MDC”) has been established as a private sector, industry focused, independent organisation to develop new approaches for the discovery and early development of new medicines helping to transform ideas into commercial products and services.

The MDC will develop and validate new ways of discovering new medicines and supporting the key UK strength in pharmaceutical, biotechnology and contract research organisations.

Latest news

MDC CELEBRATES USE OF MEDICINES DISCOVERY TECHNOLOGY IN 2016 SUNDAY TIMES HISCOX ‘TECH TRACK 100’ LEAGUE TABLE

Two of the country’s top ten fastest growing technology firms are working closely with medicines discovery technology. UKCloud, a cloud service provider who has developed a DNA sequencing project, and Immunocore, a biotech developer, are both featured in this year’s Sunday Times Hiscox Tech Track 100 league table, published on 11th September 2016, coming first and fourth in the league. […]

Read more

Connect with us